Q3 2017 13F Holders as of 30 Sep 2017
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
237M
-
Number of holders
-
17
-
Total 13F shares, excl. options
-
8.45M
-
Shares change
-
-458K
-
Total reported value, excl. options
-
$26M
-
Value change
-
-$2.12M
-
Number of buys
-
7
-
Number of sells
-
-7
-
Price
-
$3.08
Significant Holders of ADMA BIOLOGICS, INC. - COMMON STOCK (ADMA) as of Q3 2017
21 filings reported holding ADMA - ADMA BIOLOGICS, INC. - COMMON STOCK as of Q3 2017.
ADMA BIOLOGICS, INC. - COMMON STOCK (ADMA) has 17 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 8.45M shares
of 237M outstanding shares and own 3.57% of the company stock.
Largest 10 shareholders include Aisling Capital LLC (3.61M shares), Biomark Capital Management Co. LLC (1.43M shares), Consonance Capital Management LP (1.27M shares), PERCEPTIVE ADVISORS LLC (721K shares), Iguana Healthcare Management, LLC (565K shares), FMR LLC (373K shares), VANGUARD GROUP INC (312K shares), PRELUDE CAPITAL MANAGEMENT, LLC (39K shares), GEODE CAPITAL MANAGEMENT, LLC (21.5K shares), and Bank of New York Mellon Corp (21.3K shares).
This table shows the top 17 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.